George Daskalakis is an expert in Gynecology at Alexandra Hospital (Greece) (Greece). As of October 2026, ScienceLeadR ranks George Daskalakis in the top 1% of experts worldwide for Pregnancy Complications and Infertility, and in the top 1% of experts in Greece for Premature Birth. George Daskalakis has authored 842 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 2,530 (community average: 125). How the SLR is computed.

LeadR Profile

George Daskalakis Alexandra Hospital (Greece) Greece
2 530 ScienceLeadR Reputation 2530
Network Map

Gynecology

Subspecialties: Biochemistry - Obstetrics - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026

Source: PubMed

Institute of Nuclear and Particle Physics

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 842

Citations

Citations: 29 487 1st author: 69 Last author: 158 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Beyond the Embryo: Rethinking the Genetics of Recurrent Implantation Failure in the PGT-A Era.
PMID 42938286 — research design, genes, genomics, genetics, thrombophilia, aneuploidy, karyotype
Genes (Basel)20260
Transfusion Management in Pregnancies Complicated by Hemoglobinopathies: Evidence, Guidelines, and Clinical Challenges.
PMID 42936835 — hemoglobins, pregnancy, thalassemia, perinatology, hemoglobinopathies
Matern Fetal Med20260
CARTPT and FSH Signaling in Ovarian Follicle Development as an Emerging Link to Oocyte Quality and Female Infertility.
PMID 42939561 — cells, aromatase, estradiol, granulosa cells, infertility, female, leptin, ovary, infertility, oocytes, ovarian follicle
Curr Issues Mol Biol20260
Exosomes as Molecular Mediators of Reproductive Health: From Infertility to HPV-Related Disease.
PMID 42939569 — cells, extracellular vesicles, physiology, micrornas, communication, infertility, reproductive health, rna, circular, exosomes, precision medicine, therapeutics, alphapapillomavirus, reproductive medicine, human papillomavirus viruses
Curr Issues Mol Biol20260
Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link?
PMID 42532252 — thrombotic microangiopathies, pregnancy, pre-eclampsia, neutrophils, kidney, atypical hemolytic uremic syndrome, complement system proteins, therapeutics, complement activation, acute kidney injury, autoimmunity
Autoimmun Rev20261

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1

By phase:

N/A 5
Phase 3 1
Phase 4 1

By status:

Completed 2
Not yet recruiting 2
Recruiting 2
Suspended 1

By type:

Interventional 5
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 1
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Aspirin versus placebo in twin pregnancies for preeclampsia prevention A multicentre randomised double blind placebo controlled trial (ASPRE T)
2023-503698-40-00 — pregnancy, pre-eclampsia, aspirin, pregnancy, twin
Phase 3Recruiting2023
LDA and LMWH vs LDA Alone in High risk Patients for Preeclampsia Prevention
NCT07361679 — hypertension, pregnancy, high-risk, pregnancy, toxemia, pre-eclampsia, heparin, aspirin, eclampsia, pregnancy complications, tinzaparin, perinatology, hypertension, pregnancy-induced, heparin, low-molecular-weight
Phase 4Recruiting2023

LeadR Networks

Main global connection map